← Open Payments lookup

LESLIE DVORAK: Open Payments

NPI 1265422562 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$39,037 in 117 payments from 16 companies in 2025. Trend: 2023 $3,608 · 2024 $13,663 · 2025 $39,037

Speaker / faculty: $22,858Travel & lodging: $9,128Speaker / faculty: $4,362Food & beverage: $2,689
CompanyPaymentsAmount
Gilead Sciences, Inc.74$33,616
Organon LLC9$4,380
ABBVIE INC.8$361
ViiV Healthcare Company6$211
Noven Therapeutics, LLC1$121
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$95
Axsome Therapeutics, Inc.3$55
Vanda Pharmaceuticals Inc.2$51
Otsuka America Pharmaceutical, Inc.2$29
Janssen Pharmaceuticals, Inc1$23

Products named: Descovy, Yeztugo, NEXPLANON, Biktarvy, VRAYLAR, APRETUDE, Xelstrym, CAPLYTA.

Industry payments across NE — which companies pay providers there.